Tyler Zeronda - 30 Jun 2025 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Issuer symbol
VYNE
Transactions as of
30 Jun 2025
Net transactions value
-$5,643
Form type
4
Filing time
02 Jul 2025, 16:30:48 UTC
Previous filing
02 Apr 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zeronda Tyler CHIEF FINANCIAL OFFICER C/O VYNE THERAPEUTICS INC., 685 ROUTE 202/206 N, SUITE 301, BRIDGEWATER /s/ Mutya Harsch, Attorney-in-Fact 01 Jul 2025 0001867033

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $5,643 -3,420 -2.9% $1.65 115,073 30 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.